Henry Schein Stock Price, News & Analysis

Henry Schein reported fourth quarter 2020 net sales of $3.2 billion, an increase of 18.6% from Q4 2019, driven by demand for PPE and COVID-19 products. GAAP net income was $141.9 million or $0.99 per diluted share, down from $330.6 million or $2.25 per diluted share a year earlier. Non-GAAP net income rose slightly to $143.6 million or $1.00 per diluted share. Operating margins suffered from inventory adjustments and an $18.1 million impairment charge. 2021 non-GAAP EPS guidance is set at or above $3.51, excluding potential restructuring costs.

Henry Schein One has appointed Mike Baird as Chief Executive Officer, aiming to enhance growth and drive digital innovations in the dental sector. Baird, who joined the company in July 2020 as Executive Advisor, will lead all business aspects and integrate solutions across Henry Schein's offerings. His experience in health care information technology positions him as a key player in advancing the company’s mission to improve practice management and patient engagement. The leadership change is expected to strengthen the firm’s commitment to customer-focused solutions.

Henry Schein, the leading provider of healthcare solutions, announced the appointment of Mohamad Ali and Deborah Derby to its Board of Directors until the 2021 Annual Meeting. They will stand for re-election at that time. The company also confirmed the retirement of Paul Brons and the non-re-election of Shira Goodman due to other commitments, both of whom have contributed significantly to the company's growth. Ali and Derby bring extensive experience in technology and operational leadership, expected to advance the company's strategic goals.

Henry Schein (Nasdaq: HSIC) will announce its fourth quarter and full-year 2020 financial results on February 17, 2021, before the market opens. A live webcast of the earnings conference call is scheduled for the same day at 10:00 a.m. Eastern time, featuring CEO Stanley M. Bergman and CFO Steven Paladino. Investors can access the call through the company's website, with a replay available post-event. Henry Schein, a Fortune 500 company, provides healthcare solutions to dental and medical practitioners globally, reporting sales of $10 billion in 2019.

Henry Schein, Inc. (HSIC) has acquired a majority stake in Prism Medical Products, LLC, a provider of specialty home medical supplies, particularly in advanced wound care. This acquisition expands Henry Schein Medical’s reach into the multibillion-dollar home medical equipment market. Prism, founded in 2006, reported approximately $52 million in net revenue for the year ending September 30, 2020. The acquisition is expected to be neutral to earnings in 2021 and accretive thereafter. PRISM will operate as a subsidiary managed by its founder Chris Cartwright.

Henry Schein (Nasdaq: HSIC) and Casa Schmidt have established a joint venture aimed at enhancing dental practice efficiency in Spain and Portugal. Announced on March 10, 2020, and approved on June 30, 2020, the venture will leverage Henry Schein's extensive solutions portfolio and Casa Schmidt's distribution network, including Schmidt Dental Solutions, Servimed, and specialized implant products. Henry Schein will hold majority ownership, with senior management from both companies. This collaboration is expected to deliver comprehensive, high-quality services to dental professionals in the Iberian market.